Synergistic amplification of β-amyloid- and interferon-γ-induced microglial neurotoxic response by the senile plaque component chromogranin A

Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USA.
AJP Cell Physiology (Impact Factor: 3.78). 02/2005; 288(1):C169-75. DOI: 10.1152/ajpcell.00308.2004
Source: PubMed


Activation of the microglial neurotoxic response by components of the senile plaque plays a critical role in the pathophysiology of Alzheimer's disease (AD). Microglia induce neurodegeneration primarily by secreting nitric oxide (NO), tumor necrosis factor-alpha (TNFalpha), and hydrogen peroxide. Central to the activation of microglia is the membrane receptor CD40, which is the target of costimulators such as interferon-gamma (IFNgamma). Chromogranin A (CGA) is a recently identified endogenous component of the neurodegenerative plaques of AD and Parkinson's disease. CGA stimulates microglial secretion of NO and TNFalpha, resulting in both neuronal and microglial apoptosis. Using electrochemical recording from primary rat microglial cells in culture, we have shown in the present study that CGA alone induces a fast-initiating oxidative burst in microglia. We compared the potency of CGA with that of beta-amyloid (betaA) under identical conditions and found that CGA induces 5-7 times greater NO and TNFalpha secretion. Coapplication of CGA with betaA or with IFNgamma resulted in a synergistic effect on NO and TNFalpha secretion. CD40 expression was induced by CGA and was further increased when betaA or IFNgamma was added in combination. Tyrphostin A1 (TyrA1), which inhibits the CD40 cascade, exerted a dose-dependent inhibition of the CGA effect alone and in combination with IFNgamma and betaA. Furthermore, CGA-induced mitochondrial depolarization, which precedes microglial apoptosis, was fully blocked in the presence of TyrA1. Our results demonstrate the involvement of CGA with other components of the senile plaque and raise the possibility that a narrowly acting agent such as TyrA1 attenuates plaque formation.

Download full-text


Available from: Mark A Messerli, Mar 06, 2014
  • Source
    • "In our study, fAβ or oAβ alone failed to activate BV-2 cells to produce nitric oxide. The potential reasons for this could be attributed to fAβ may only activate the IFN-γ-primed microglia [8,27]. In our present results, fAβ, but not oAβ, enhanced the nitric oxide production through the promotion of iNOS expression in the IFN-γ-primed BV-2 cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Microglial inflammation may significantly contribute to the pathology of Alzheimer's disease. To examine the potential of Cudrania cochinchinensis to ameliorate amyloid beta protein (Abeta)-induced microglia activation, BV-2 microglial cell line, and the ramified microglia in the primary glial mixed cultured were employed. Lipopolysaccharide (LPS), Interferon-gamma (IFN-gamma), fibrillary Abeta (fAbeta), or oligomeric Abeta (oAbeta) were used to activate microglia. LPS and IFN-gamma, but not Abetas, activated BV-2 cells to produce nitric oxide through an increase in inducible nitric oxide synthase (iNOS) expression without significant effects on cell viability of microglia. fAbeta, but not oAbeta, enhanced the IFN-gamma-stimulated nitric oxide production and iNOS expression. The ethanol/water extracts of Cudrania cochinchinensis (CC-EW) and the purified isolated components (i.e. CCA to CCF) effectively reduced the nitric oxide production and iNOS expression stimulated by IFN-gamma combined with fAbeta. On the other hand, oAbeta effectively activated the ramified microglia in mixed glial culture by observing the morphological alteration of the microglia from ramified to amoeboid. CC-EW and CCB effectively prohibit the Abeta-mediated morphological change of microglia. Furthermore, CC-EW and CCB effectively decreased Abeta deposition and remained Abeta in the conditioned medium suggesting the effect of CC-EW and CCB on promoting Abeta clearance. Results are expressed as mean +/- S.D. and were analyzed by ANOVA with post-hoc multiple comparisons with a Bonferroni test. The components of Cudrania cochinchinensis including CC-EW and CCB are potential for novel therapeutic intervention for Alzheimer's disease.
    Journal of Biomedical Science 08/2013; 20(1):55. DOI:10.1186/1423-0127-20-55 · 2.76 Impact Factor
  • Source
    • "Chromogranins are soluble glycophosphoproteins capable of activating microglial cells and metabotropic glutamate receptors [60]. Chromogranin A might synergistically enhance with beta-amyloid peptides the microglial neurotoxic effect and diminish microglial phagocytic activity in senile plaques [61]. Chromogranin A was recently discovered to bind to mutant superoxid dismutase activity in amyotrophic lateral sclerosis increasing neurotoxicity [62]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Today, dementias are diagnosed late in the course of disease. Future treatments have to start earlier in the disease process to avoid disability requiring new diagnostic tools. The objective of this study is to develop a new method for the differential diagnosis and identification of new biomarkers of Alzheimer's disease (AD) using capillary-electrophoresis coupled to mass-spectrometry (CE-MS) and to assess the potential of early diagnosis of AD. Cerebrospinal fluid (CSF) of 159 out-patients of a memory-clinic at a University Hospital suffering from neurodegenerative disorders and 17 cognitively-healthy controls was used to create differential peptide pattern for dementias and prospective blinded-comparison of sensitivity and specificity for AD diagnosis against the Criterion standard in a naturalistic prospective sample of patients. Sensitivity and specificity of the new method compared to standard diagnostic procedures and identification of new putative biomarkers for AD was the main outcome measure. CE-MS was used to reliably detect 1104 low-molecular-weight peptides in CSF. Training-sets of patients with clinically secured sporadic Alzheimer's disease, frontotemporal dementia, and cognitively healthy controls allowed establishing discriminative biomarker pattern for diagnosis of AD. This pattern was already detectable in patients with mild cognitive impairment (MCI). The AD-pattern was tested in a prospective sample of patients (n = 100) and AD was diagnosed with a sensitivity of 87% and a specificity of 83%. Using CSF measurements of beta-amyloid1-42, total-tau, and phospho(181)-tau, AD-diagnosis had a sensitivity of 88% and a specificity of 67% in the same sample. Sequence analysis of the discriminating biomarkers identified fragments of synaptic proteins like proSAAS, apolipoprotein J, neurosecretory protein VGF, phospholemman, and chromogranin A. The method may allow early differential diagnosis of various dementias using specific peptide fingerprints and identification of incipient AD in patients suffering from MCI. Identified biomarkers facilitate face validity for the use in AD diagnosis.
    PLoS ONE 10/2011; 6(10):e26540. DOI:10.1371/journal.pone.0026540 · 3.23 Impact Factor
  • Source
    • "NPC cells displayed a number of changes in gene expression that are associated with the generation of reactive oxygen and nitrogen species (Table 4). CHGA (chromogranin A), a component of Alzheimer's disease plaques [46], induces nitric oxide efflux from microglia, a key step in neurodegeneration [47]. Components of the phagocytic NADPH oxidase (CYBB, NCF4) that can generate reactive oxygen species were upregulated [48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Niemann-Pick Type C (NPC) disease is a neurodegenerative disease that is characterized by the accumulation of cholesterol and glycosphingolipids in the late endocytic pathway. The majority of NPC cases are due to mutations in the NPC1 gene. The precise function of this gene is not yet known. Using cDNA microarrays, we analyzed the genome-wide expression patterns of human fibroblasts homozygous for the I1061T NPC1 mutation that is characterized by a severe defect in the intracellular processing of low density lipoprotein-derived cholesterol. A distinct gene expression profile was identified in NPC fibroblasts from different individuals when compared with fibroblasts isolated from normal subjects. As expected, NPC1 mutant cells displayed an inappropriate homeostatic response to accumulated intracellular cholesterol. In addition, a number of striking parallels were observed between NPC disease and Alzheimer's disease. Many genes involved in the trafficking and processing of amyloid precursor protein and the microtubule binding protein, tau, were more highly expressed. Numerous genes important for membrane traffic and the cellular regulation of calcium, metals and other ions were upregulated. Finally, NPC fibroblasts exhibited a gene expression profile indicative of oxidative stress. These changes are likely contributors to the pathophysiology of Niemann-Pick Type C disease.
    PLoS ONE 02/2006; 1(1):e19. DOI:10.1371/journal.pone.0000019 · 3.23 Impact Factor
Show more